Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
Published: January 14, 2021
Abstract Views: 1514
PDF: 778
Supplementary: 124
Supplementary: 124
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Paola Gargiulo, Carmen D'Amore, Santo Dellegrottaglie, Dario Leosco, Giuseppe Rengo, Francesca Musella, Elisabetta Pirozzi, Susanna Mosca, Laura Casaretti, Roberto Formisano, Ada Bologna, Antonio Parente, Sirio Conte, Pasquale Perrone-Filardi, From myocardium to the atherosclerotic plaque: new perspectives in cardiologic imaging , Monaldi Archives for Chest Disease: Vol. 76 No. 2 (2011): Cardiac series
- Shayan Shahid, Ali bin Abdul Jabbar, Abdullah Wagley, Muhammad Daniyal Musharraf, Haris Zahid, Syed Muhammad Zubair, Muhammad Irfan, Non-cystic fibrosis bronchiectasis: a retrospective review of clinical, radiological, microbiological and lung function profile at a tertiary care center of low-middle income country , Monaldi Archives for Chest Disease: Early Access
- Shivam Garg, Pratap Upadhya, Arul Kumar, Norton Stephen, Bala Subramanian, Overcoming the challenges of a misdiagnosed rare lung disease – idiopathic pleuroparenchymal fibroelastosis , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Oleksandr Korotych, Andrei Dadu, Askar Yedilbayev, Masoud Dara, Operational research as an instrument to address the critical gaps for effective treatment of tuberculosis in eastern Europe and central Asia , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Mariarosaria De Luca, Giulia Crisci, Federica Giardino, Valeria Valente, Ilaria Amaranto, Olimpia Iacono, Roberta D'Assante, Francesco Giallauria, Alberto M. Marra, Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne’s thread , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Marika Werren, Roberto Copetti, Nicola Gaibazzi, Franco Giada, Andrea Faggiano, Chiara Ricci, Pompilio Faggiano, Choosing wisely in cardiology: Five proposals from the Italian Association for Cardiovascular Prevention and Rehabilitation , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- Shekhar Kunal, Vijay Pathak, Keshav Pathak, Monika Mishra, Shashi Mohan Sharma, Sudhir Bhandari, Very late stent thrombosis associated with COVID-19 infection: a case report and review of the literature , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Carlo Uran, Through the heart and beyond: a review on ranolazine , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Miguel Martins Carvalho, Ricardo Alves Pinto, Tânia Proença, Inês Costa, Nuno Tavares, Mariana Paiva, Carla Sousa, Filipe Macedo, Cardiovascular toxicity in breast cancer patients – contributors and role of cardioprotective drugs , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Bhupen Barman, Arvind Nune, Pranav Ish, Pranjal Phukan, Donboklang Lynser, Hem Raj Sapkota, Complete persistent remission of rheumatoid arthritis after COVID-19 infection - A rare case and literature review , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
You may also start an advanced similarity search for this article.